BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 15211609)

  • 1. Endocrine disrupters and human health: could oestrogenic chemicals in body care cosmetics adversely affect breast cancer incidence in women?
    Harvey PW; Darbre P
    J Appl Toxicol; 2004; 24(3):167-76. PubMed ID: 15211609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parabens, oestrogenicity, underarm cosmetics and breast cancer: a perspective on a hypothesis.
    Harvey PW
    J Appl Toxicol; 2003; 23(5):285-8. PubMed ID: 12975767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental oestrogens, cosmetics and breast cancer.
    Darbre PD
    Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):121-43. PubMed ID: 16522524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
    Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of the detection of esters of p-hydroxybenzoic acid (parabens) in human breast tumours.
    Harvey PW; Everett DJ
    J Appl Toxicol; 2004; 24(1):1-4. PubMed ID: 14745840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks.
    Darbre PD; Harvey PW
    J Appl Toxicol; 2008 Jul; 28(5):561-78. PubMed ID: 18484575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of endocrine-disrupting chemicals: critical overview and deficiencies in toxicology and risk assessment for human health.
    Harvey PW; Everett DJ
    Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):145-65. PubMed ID: 16522525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The health controversies of parabens.
    Kirchhof MG; de Gannes GC
    Skin Therapy Lett; 2013 Feb; 18(2):5-7. PubMed ID: 23508773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer, oestrogens and environmental pollutants: a re-evaluation from a mixture perspective.
    Kortenkamp A
    Int J Androl; 2006 Feb; 29(1):193-8. PubMed ID: 16466540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety assessment of personal care products/cosmetics and their ingredients.
    Nohynek GJ; Antignac E; Re T; Toutain H
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):239-59. PubMed ID: 20005888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatase inhibiting and combined estrogenic effects of parabens and estrogenic effects of other additives in cosmetics.
    van Meeuwen JA; van Son O; Piersma AH; de Jong PC; van den Berg M
    Toxicol Appl Pharmacol; 2008 Aug; 230(3):372-82. PubMed ID: 18486175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of parabens in human breast tumours.
    Darbre PD; Aljarrah A; Miller WR; Coldham NG; Sauer MJ; Pope GS
    J Appl Toxicol; 2004; 24(1):5-13. PubMed ID: 14745841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oestrogenic activity of p-hydroxybenzoic acid (common metabolite of paraben esters) and methylparaben in human breast cancer cell lines.
    Pugazhendhi D; Pope GS; Darbre PD
    J Appl Toxicol; 2005; 25(4):301-9. PubMed ID: 16021681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Parabenoia" Debunked, or "Who's Afraid of Parabens?".
    Sasseville D; Alfalah M; Lacroix JP
    Dermatitis; 2015; 26(6):254-9. PubMed ID: 26551603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety assessment of esters of p-hydroxybenzoic acid (parabens).
    Soni MG; Carabin IG; Burdock GA
    Food Chem Toxicol; 2005 Jul; 43(7):985-1015. PubMed ID: 15833376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental oestrogens and breast cancer: evidence for combined involvement of dietary, household and cosmetic xenoestrogens.
    Darbre PD; Charles AK
    Anticancer Res; 2010 Mar; 30(3):815-27. PubMed ID: 20393002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personal care products and endocrine disruption: A critical review of the literature.
    Witorsch RJ; Thomas JA
    Crit Rev Toxicol; 2010 Nov; 40 Suppl 3():1-30. PubMed ID: 20932229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parabens: potential impact of low-affinity estrogen receptor binding chemicals on human health.
    Karpuzoglu E; Holladay SD; Gogal RM
    J Toxicol Environ Health B Crit Rev; 2013; 16(5):321-35. PubMed ID: 23909435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of paraben concentrations in human breast tissue at serial locations across the breast from axilla to sternum.
    Barr L; Metaxas G; Harbach CA; Savoy LA; Darbre PD
    J Appl Toxicol; 2012 Mar; 32(3):219-32. PubMed ID: 22237600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.